Shares of Colgate-Palmolive Company (NYSE:CL) have been given a consensus rating of “Hold” by the eighteen brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $75.67.

A number of equities research analysts have recently issued reports on CL shares. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 3rd. Jefferies Group LLC restated a “hold” rating and set a $76.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, May 17th. Bank of America Corporation boosted their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, May 31st. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Thursday, March 23rd. Finally, Vetr cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a report on Wednesday, May 17th.

Shares of Colgate-Palmolive (NYSE:CL) traded up 1.64% during mid-day trading on Friday, hitting $73.27. The company’s stock had a trading volume of 7,173,140 shares. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a 50-day moving average of $74.80 and a 200 day moving average of $72.20. The company has a market cap of $64.72 billion, a price-to-earnings ratio of 26.44 and a beta of 0.80. Colgate-Palmolive also saw unusually large options trading on Thursday. Stock investors purchased 11,545 put options on the company. This represents an increase of approximately 508% compared to the typical volume of 1,900 put options.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 3,725.55% and a net margin of 16.31%. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. During the same quarter in the previous year, the company posted $0.70 earnings per share. The business’s revenue was down .5% on a year-over-year basis. On average, analysts expect that Colgate-Palmolive will post $2.93 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, July 14th. This represents a $1.60 annualized dividend and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio is currently 57.76%.

WARNING: “Colgate-Palmolive Company (CL) Given Average Rating of “Hold” by Brokerages” was posted by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/07/21/colgate-palmolive-company-cl-given-average-rating-of-hold-by-brokerages.html.

In other Colgate-Palmolive news, Director Richard J. Kogan sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $71.92, for a total transaction of $575,360.00. Following the completion of the transaction, the director now directly owns 73,065 shares in the company, valued at $5,254,834.80. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $71.53, for a total transaction of $1,001,420.00. Following the transaction, the senior vice president now owns 102,838 shares of the company’s stock, valued at $7,356,002.14. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 29,666 shares of company stock valued at $2,144,371. Company insiders own 1.02% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in CL. American Beacon Advisors Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $102,000. Advantage Investment Management LLC purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $104,000. Proficio Capital Partners LLC increased its position in shares of Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after buying an additional 207 shares in the last quarter. Harbour Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $121,000. Finally, AlphaMark Advisors LLC increased its position in shares of Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock valued at $122,000 after buying an additional 1,370 shares in the last quarter. Institutional investors and hedge funds own 73.50% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.